Cancer BiologyiSciencePeer-reviewed
MYC dosage compensation is mediated by miRNA-transcription factor interactions in aneuploid cancer
M. S. Acon, C. Geiss, J. Torres-Calvo…·R. M. Mora-Rodriguez
This study identifies miRNA-transcription factor interactions that mediate MYC dosage compensation in aneuploid cancer, showing a negative correlation with patient survival in breast cancer.
DOI 10.1016/j.isci.2021.103407